Study: Low-dose PET/CT best for lymphoma staging

12/8/2008 | Diagnostic Imaging

A Spanish study found that low-dose PET/CT achieved the best sensitivity and specificity for the initial staging of biopsy-proven non-Hodgkin's lymphoma and Hodgkin's lymphoma compared with contrast-enhanced CT. This imaging method could reduce the radiation dose and eliminate the need for intravenous iodinated contrast materials, the lead researcher said.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN